Frailty check could personalize bladder cancer care for seniors

This study looks at whether a short survey called the Geriatric-8 can help doctors choose the best treatment for older patients with advanced bladder cancer who cannot take the strong chemotherapy drug cisplatin. Researchers will compare quality of life and side effects between two treatment approaches: one using a milder chemo followed by immunotherapy, and another using a newer drug combo. The goal is to find out which treatment works better for frail or at-risk patients.